<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Lorestan University of Medical Sciences</PublisherName>
				<JournalTitle>Herbal Medicines Journal</JournalTitle>
				<Issn>2538-2144</Issn>
				<Volume>9</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>A Snapshot on the Development of Quinolones and Fluoroquinolones - An Origin of Nalidixic Acid</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>11</LastPage>
			<ELocationID EIdType="pii">220950</ELocationID>
			
<ELocationID EIdType="doi">10.22087/hmj.v9i2</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sharma</FirstName>
					<LastName>Manoj Kumar</LastName>
<Affiliation>School of Pharmaceutical Sciences Apeejay Stya University, Gurugram, Haryana, India

Amity Institute of Pharmacy, Amity University, Gurugram, Haryana, India</Affiliation>

</Author>
<Author>
					<FirstName>Kumawat</FirstName>
					<LastName>Mukesh Kumar</LastName>
<Affiliation>School of Pharmaceutical Sciences Apeejay Stya University, Gurugram, Haryana, India</Affiliation>

</Author>
<Author>
					<FirstName>Diwan</FirstName>
					<LastName>Anupama</LastName>
<Affiliation>School of Pharmaceutical Sciences Apeejay Stya University, Gurugram, Haryana, India</Affiliation>

</Author>
<Author>
					<FirstName>Sardana</FirstName>
					<LastName>Satish</LastName>
<Affiliation>Amity Institute of Pharmacy, Amity University, Gurugram, Haryana, India</Affiliation>

</Author>
<Author>
					<FirstName>Yadav</FirstName>
					<LastName>Narender</LastName>
<Affiliation>School of Pharmaceutical Sciences Apeejay Stya University, Gurugram, Haryana, India</Affiliation>

</Author>
<Author>
					<FirstName>Kumar</FirstName>
					<LastName>Brijesh</LastName>
<Affiliation>Department of nursing, Patna Medical College Hospital, Patna, Bihar, India


Amity College of Nursing, Amity University, Gurugram, Haryana, India</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>05</Month>
					<Day>17</Day>
				</PubDate>
			</History>
		<Abstract>Quinolone antibacterial molecules are the most impactful types of anti-infective, active pharmaceutical&lt;br /&gt;ingredients in our never-ending battle against pathogens. Additionally, in contrast to many anti-infective classes,&lt;br /&gt;the discoverers published a startlingly small amount of information regarding the origin of the class or the&lt;br /&gt;justification for this significant group&#039;s first FDA-approved agent, nalidixic acid. With an emphasis on the&lt;br /&gt;Quantitative Structure-Activity Relationship (QSAR), chemistry, development, adverse effect, and future aspects&lt;br /&gt;of this class of antibiotics, this article discusses the discovery, total synthetic methods, pharmacology, clinical&lt;br /&gt;applications, and further lead to the new pipeline that produced various large selling and widely used antibiotics.&lt;br /&gt;Keywords: Nalidixic Acid, Synthesis, Development, Quinolones, Fluoroquinolones</Abstract>
<ArchiveCopySource DocType="pdf">https://hmj.lums.ac.ir/article_220950_8d4eb6d361a0db9ff389a054f248c8ed.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
